Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

MLA

Gramatzki, Dorothee, et al. “Limited Role for Extended Maintenance Temozolomide for Newly Diagnosed Glioblastoma.” Neurology, vol. 88, no. 15, Apr. 2017, pp. 1422–30. EBSCOhost, https://doi.org/10.1212/WNL.0000000000003809.

APA

Gramatzki, D., Kickingereder, P., Hentschel, B., Felsberg, J., Herrlinger, U., Schackert, G., Tonn, J.-C., Westphal, M., Sabel, M., Schlegel, U., Wick, W., Pietsch, T., Reifenberger, G., Loeffler, M., Bendszus, M., & Weller, M. (2017). Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma. Neurology, 88(15), 1422–1430. https://doi.org/10.1212/WNL.0000000000003809

Chicago

Gramatzki, Dorothee, Philipp Kickingereder, Bettina Hentschel, Jörg Felsberg, Ulrich Herrlinger, Gabriele Schackert, Jörg-Christian Tonn, et al. 2017. “Limited Role for Extended Maintenance Temozolomide for Newly Diagnosed Glioblastoma.” Neurology 88 (15): 1422–30. doi:10.1212/WNL.0000000000003809.